<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83214">
  <stage>Registered</stage>
  <submitdate>26/09/2008</submitdate>
  <approvaldate>7/11/2008</approvaldate>
  <actrnumber>ACTRN12608000559314</actrnumber>
  <trial_identification>
    <studytitle>Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline) - Pilot study.</studytitle>
    <scientifictitle>Reducing impulsive behaviour in repeat violent offenders using a Selective Serotonin Reuptake Inhibitor (Sertraline) - Pilot study.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Impulsivity 
Violence</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Other mental health disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Oral Selective Serotonin Reuptake Inhibitor 100mg daily for 3 months.</interventions>
    <comparator>N/A</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Impulsive behaviour as measured on the Barratt Impulsiveness Scale.</outcome>
      <timepoint>1 month &amp; 3 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Depression (Beck Depression Inventory)</outcome>
      <timepoint>1 month &amp; 3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Psychological distress (Kessler Psychological distress Scale - K10)</outcome>
      <timepoint>1 month &amp; 3 months</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Aggressive behaviour (Anger, Irritability, Aggression Questionnaire - AIAQ)</outcome>
      <timepoint>1 month &amp; 3 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Men
At least 1 prior conviction for violence
Score over 70 on an impulsivity screener</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Current medications include a Selective Serotonin Reuptake Inhibitor (SSRI) or other antidepressant (especially a Mono Amine Oxidase Inhibitor) or anti-psychotics.
Severe mental illness.
History of adverse drug reactions to a Selective Serotonin Reuptake Inhibitor (SSRI).
Past conviction for murder, manslaughter or sexual assault.
Regular use of amphetamine.
From remote/inaccessible area.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment />
    <sequence />
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/07/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>NSW Justice Health</primarysponsorname>
    <primarysponsoraddress>PO Box 150
Matraville NSW 2036</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Other</fundingtype>
      <fundingname>NSW Justice Health</fundingname>
      <fundingaddress>PO Box 150
Matraville NSW 2036</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>National Drug Research Institute</sponsorname>
      <sponsoraddress>PO Box U1987
Perth WA 6845</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>National Drug Research Institute</sponsorname>
      <sponsoraddress>PO Box U1987
Perth 6845</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Government body</othercollaboratortype>
      <othercollaboratorname>Hunter New England Health</othercollaboratorname>
      <othercollaboratoraddress>Postal Address
PO Box 833, Newcastle
NSW 2300</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Hunter New England Health</othercollaboratorname>
      <othercollaboratoraddress>PO Box 833, Newcastle
NSW 2300</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine whether SSRI are effective in reducing impulsive behaviour in repeat violent offenders.</summary>
    <trialwebsite>N/A</trialwebsite>
    <publication>N/A</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>NSW Justice Health</ethicname>
      <ethicaddress>PO Box 150
Matraville NSW 2036</ethicaddress>
      <ethicapprovaldate>1/12/2006</ethicapprovaldate>
      <hrec>GEN59/06</hrec>
      <ethicsubmitdate>1/11/2006</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Tony Butler</name>
      <address>National Drug Research Institute
PO Box U1987
Perth WA 6845</address>
      <phone>08 9266 1616</phone>
      <fax>08 9266 1611</fax>
      <email>t.butler@curtin.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tony Butler</name>
      <address>National Drug Research Institute
PO Box U1987
Perth WA 6845</address>
      <phone>08 9266 1616</phone>
      <fax>08 9266 1611</fax>
      <email>t.butler@curtin.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Tony Butler</name>
      <address>National Drug Research Institute
PO Box U1987
Perth WA 6845</address>
      <phone>08 9266 1616</phone>
      <fax>08 9266 1611</fax>
      <email>t.butler@curtin.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>